ANGPT1 and acute respiratory distress syndrome: Mei et al. (2007) reported that treatment with MSCs alone significantly reduced Lipopolysaccharide (LPS)-induced acute pulmonary inflammation in mice, whereas administration of MSCs transfected with the human ANGPT1 plasmid resulted in further improvement by completely reversing LPS-induced permeability in the lung of the ALI model [13].